publication venue for
- Ocrelizumab: a B-cell depleting therapy for multiple sclerosis.. 17:1163-1172. 2017
- Use of natalizumab in multiple sclerosis: current perspectives.. 16:1151-62. 2016
- Biomaterials and stem cells for tissue engineering.. 13:527-40. 2013